Table 2.

Analysis summary of Karipidis et al. epidemiological study review (Table 7 in their review publication).

Critique Category	Description
Undisclosed Disease Risk	There were a total of eight instances identified in our analysis where epidemiological studies that identified important health risks, such as specific cancers, were not disclosed in the disease column for studies in Table 7 of the Karipidis 5G Health review.
Incorrect Case/Personnel Numbers	There were a number of instances where studies presented by Karipidis had case/personnel number discrepancies not matching actual published numbers or included case and control counts not included in the scope for review (i.e., <6 GHz).
Incorrect Odds Ratio Assignment	One instance was found where an Odds Ratio (OR) for an occupational exposure provided by Karipidis was not in the scope of review (wrong exposure type i.e., <6 GHz).
Limitations Misstatement	There were two instances where Karipidis claimed “no information on confounding factors” was found to be incorrect.
Risk Estimate Issue	Karipidis has incorrectly specified Odds Ratio in three instances where a different type of rate or ratio was used.